HOTH vs JNJ · rev $1.24B vs P/E 17, rev $49.37B
Hoth Therapeutics Inc (HOTH) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
HOTH currently screens at market cap $15.5M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the HOTH and JNJ stock pages for the full models.
Not investment advice.